![Patricia Allen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 365 424 $ al 31/05/2026
Patricia L.
Allen is currently Director at Anokion SA since 2020, Director at Kanyos Bio, Inc., Independent Director at Inversago Pharma, Inc., Non-Executive Director at SwanBio Therapeutics, Inc. since 2020, and Independent Director at Zenas BioPharma, Inc. since 2024.
Former roles include Finance Director at Alkermes, Inc. from 1992 to 2004, Director at Yumanity, Inc. from 2019 to 2020, Independent Director at Deciphera Pharmaceuticals, Inc. from 2016 to 2024, Independent Director at Yumanity Therapeutics, Inc. from 2020 to 2022, CFO, Treasurer & Principal Accounting Officer at Zafgen, Inc. from 2013 to 2020, Auditor at Deloitte & Touche LLP, Chief Financial Officer, Treasurer & VP at Alnylam Pharmaceuticals, Inc. in 2010, and Chief Financial Officer at Vividion Therapeutics, Inc. from 2021 to 2024.
Education includes undergraduate studies at Bryant University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,03 % | 15/06/2026 | 19.860 ( 0,03 % ) | 365 424 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Director/Miembro de la Junta | - |
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Director/Miembro de la Junta | 29/09/2020 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Director/Miembro de la Junta | 20/11/2020 |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 11/06/2024 |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Director Financiero/CFO | 01/01/2024 |
| YUMANITY THERAPEUTICS | Director/Miembro de la Junta | 01/12/2022 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Director/Miembro de la Junta | 22/12/2020 |
| LARIMAR THERAPEUTICS, INC. | Director Financiero/CFO | 01/05/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Health Technology |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops therapeutics for neurological disorders | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
